サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1730667

末梢血管デバイスの世界市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Peripheral Vascular Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 248 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
末梢血管デバイスの世界市場：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年
出版日: 2025年05月22日
発行: Market Xcel - Markets and Data
ページ情報: 英文 248 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢血管デバイスの市場規模は、2025年～2032年の予測期間中に6.23％のCAGRで拡大し、2024年の104億9,000万米ドルから2032年には170億1,000万米ドルに成長すると予測されています。この市場の成長は、血管の健康が重視されるようになったこと、臨床試験の数が増えていること、世界中のさまざまな地域で末梢動脈疾患（PAD）を含むさまざまな心臓疾患の有病率が高まっていることに起因しています。米国心臓協会は、PADは世界中で約2億人が罹患していると推定していますが、特定の人口集団はPADの臨床的影響と有病率が高くなっています。

血管疾患の主要な危険因子である肥満、糖尿病、高血圧を含む生活習慣病の増加により、新規で先進的かつ効率的な血管インターベンションに対する需要が増え続けています。啓蒙キャンペーンの増加、政府の取り組み、画像診断技術の進歩により、医療専門家が疾患の早期診断を行い、早期に治療を開始できるようになり、市場の拡大を支えています。

心血管・血管障害の増加も市場の需要を後押ししています。動脈硬化、PAD、静脈瘤などの疾患は、座りがちなライフスタイル、高齢化社会の拡大、食生活の乱れなどが原因で、ますます一般的になりつつあります。このような疾患の有病率の高さは、早期診断と治療のために現代的で効率的かつ低侵襲なソリューションを導入するよう医療専門家に促しています。末梢血管デバイスの進歩により、ヘルスケア専門家は閉塞を治療し、血流を促進し、脳卒中や切断の可能性を減らすことができます。

当レポートでは、世界の末梢血管デバイス市場について調査し、市場の概要とともに、製品タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界の末梢血管デバイス市場の見通し、2018年～2032年

  • 市場規模分析と予測
  • 市場シェア分析と予測
    • 製品タイプ別
      • 末梢血管ステント
      • 血管形成術用バルーン
      • プラーク修正デバイス
      • 下大静脈（IVC）フィルター
      • 血行動態血流調節デバイス
      • カテーテル
      • その他
    • 用途別
      • 末梢動脈疾患（PAD）
      • 動脈瘤
      • 静脈血栓塞栓症
      • その他
    • エンドユーザー別
      • 病院と外科センター
      • 外来手術センター（ASC）
      • 学術研究機関
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ
    • 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
  • 2024年の市場マップ分析

第6章 北米の末梢血管デバイス市場の見通し、2018年～2032年

  • 市場規模分析と予測
  • 市場シェア分析と予測
  • 国別市場評価
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の末梢血管デバイス市場の見通し、2018年～2032年

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第8章 アジア太平洋の末梢血管デバイス市場の見通し、2018年～2032年

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米の末梢血管デバイス市場の見通し、2018年～2032年

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカの末梢血管デバイス市場の見通し、2018年～2032年

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第11章 需要供給分析

第12章 輸出入の分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 価格分析

第17章 市場力学

  • 市場の促進要因
  • 市場の課題

第18章 市場動向と発展

第19章 規制状況

第20章 製品の発売とイノベーション

第21章 ケーススタディ

第22章 競合情勢

  • 市場リーダートップ5の競合マトリックス
  • 参入企業トップ5のSWOT分析
  • 市場の主要企業トップ10の情勢
    • Boston Scientific Corporation
    • Koninklijke Philips N.V
    • Abbott Laboratories
    • Edward Lifesciences Corporation
    • Medtronic Inc.
    • Teleflex Incorporated
    • Becton, Dickinson, and Company
    • Edward Lifesciences Corporation
    • Terumo Corporation
    • Stryker Corporation

第23章 戦略的提言

第24章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 3. Global Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 4. Global Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global Peripheral Vascular Devices Market Share (%), By Region, 2018-2032F
  • Figure 6. North America Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 8. North America Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 9. North America Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 11. United States Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 13. United States Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 14. United States Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 17. Canada Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 18. Canada Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 21. Mexico Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 22. Mexico Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 25. Europe Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 26. Europe Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 30. Germany Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 31. Germany Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 32. France Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 34. France Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 35. France Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 38. Italy Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 39. Italy Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 42. United Kingdom Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 43. United Kingdom Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 46. Russia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 47. Russia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 50. Netherlands Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 51. Netherlands Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 54. Spain Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 55. Spain Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 58. Turkey Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 59. Turkey Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 62. Poland Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 63. Poland Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 66. South America Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 67. South America Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 71. Brazil Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 72. Brazil Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 75. Argentina Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 76. Argentina Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 79. Asia-Pacific Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 80. Asia-Pacific Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 82. India Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 84. India Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 85. India Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 86. China Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 88. China Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 89. China Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 92. Japan Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 93. Japan Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 96. Australia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 97. Australia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 100. Vietnam Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 101. Vietnam Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 104. South Korea Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 105. South Korea Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 108. Indonesia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 109. Indonesia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 112. Philippines Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 113. Philippines Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 116. Middle East & Africa Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 117. Middle East & Africa Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa Peripheral Vascular Devices Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 121. Saudi Arabia Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 122. Saudi Arabia Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 125. UAE Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 126. UAE Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa Peripheral Vascular Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa Peripheral Vascular Devices Market Share (%), By Product Type, 2018-2032F
  • Figure 129. South Africa Peripheral Vascular Devices Market Share (%), By Application, 2018-2032F
  • Figure 130. South Africa Peripheral Vascular Devices Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13152

Global peripheral vascular devices market is projected to witness a CAGR of 6.23% during the forecast period 2025-2032, growing from USD 10.49 billion in 2024 to USD 17.01 billion in 2032. The market's growth can be attributed to the rising emphasis on vascular health, the increasing number of clinical trials, and growing prevalence of various cardiac conditions, including peripheral arterial disease (PAD) in different regions across the globe. The American Heart Association estimates that PAD affects approximately 200 million individuals across the globe, though certain demographic groups experience higher clinical effects and prevalence of PAD.

There is an ever-increasing demand for novel, advanced, and efficient vascular interventions due to the rise in lifestyle disorders including obesity, diabetes mellitus, and hypertension, major risk factors for vascular diseases. The rising number of awareness campaigns, government initiatives, and advancements in diagnostic imaging technology are allowing healthcare professionals to provide early diagnosis of the condition and start the treatment sooner, supporting the market's expansion.

The rise in the number of cardiovascular and vascular disorders is also bolstering the market's demand. Conditions such as atherosclerosis, PAD, and varicose veins are becoming increasingly common, due to sedentary lifestyles, expansion of the aging population, and poor dietary habits. The high prevalence of such conditions is encouraging medical professionals to introduce modern, efficient, and minimally invasive solutions for early diagnosis and treatment. Advancements in peripheral vascular devices are allowing healthcare professionals to treat blockages, facilitate blood flow, and reduce the chances of stroke and amputation.

Technological Innovations Drive Market Growth

Technological advancements are allowing the leading market players to improve the safety, performance, and effectiveness of peripheral vascular interventions, thus improving patient outcomes. Easy availability of the newer generation of the drug-eluting stent and balloon, bioresorbable scaffolds, and newer guidewire technologies have led to improved procedural precision. Additionally, imaging-guided interventions have changed vascular surgery by assisting accurate navigation in real-time, fewer complications in procedures, and higher accuracy. The companies are also heavily investing in research and development to bring to devices that are easy to use, flexible, and durable, enhancing physician convenience. Artificial intelligence and machine learning algorithms have now begun to enter vascular diagnostics to prioritize personalized treatment plans and earlier detection of disease. These technological advancements are giving better clinical outcomes and making vascular procedures more cost-effective, thus encouraging companies to expand their product portfolios. For instance, in September 2024, Shockwave Medical, Inc. launched the Shockwave E8 Peripheral IVL Catheter, following clearance by the U.S. FDA. The catheter is designed for optimizing the treatments for patients with below the knee PAD and calcified femoropopliteal.

Rising Research Activities Support Market Expansion

Research activities drive market growth by improving clinical outcomes, fostering innovation, and bolstering the selection of treatment options available. Rising investments in research studies and clinical trials by leading market players and medical device companies are propelling the availability of advanced technologies and medical solutions such as novel stent systems, drug-coated balloons, and atherectomy devices. Such innovations address the complex vascular disorders in a more effective manner, enhancing the quality of life and safety of the patient population, bolstering the demand for novel, innovative solutions.

Additionally, the key players of the market are also investing in research studies and clinical trials to demonstrate the effectiveness and safety of various peripheral vascular devices to boost physician confidence and propel their utilization. For instance, in November 2024, Abbott Laboratories released data from the second year of the LIFE-BTK clinical trial that demonstrated the effectiveness of Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK) in patients with severe PAD below the knee.

Angioplasty Balloons Account for Significant Share of the Market

The segment's dominance can be attributed to the rising prevalence of cardiovascular diseases, especially coronary artery disease. These medical devices are used during minimally invasive procedures to open blocked or narrow arteries, reducing symptoms such as PAD and angina, by restoring effective blood flow. The rising efforts of the leading market players to introduce technologically advanced devices including drug-coated balloons to reduce the risk of restenosis and improve patient outcomes is further supporting the segment's expansion.

As the aging population expands and the incidences of obesity continue to rise, the preference for minimally invasive procedures is increasing, thus encouraging the leading medical device companies to introduce new products and technologies. For instance, in August 2024, Teleflex Incorporated received 510(k) clearance from the Food and Drug Administration (FDA) for its percutaneous transluminal coronary angioplasty perfusion balloon catheter for balloon dilation of coronary artery and coronary bypass graft stenoses.

North America Holds Major Market Share

The market's growth in North America can be attributed to the expansion of the geriatric population, advancements in medical technology, easy availability and adoption of novel medical solutions, and rising incidences of PAD in countries such as the United States and Canada. As per the estimates of the American Heart Association, 7-12 million individuals in the United States suffer from PAD. The increasing prevalence of PAD can be attributed to the rising cases of diabetes, high blood pressure, and smoking.

Meanwhile, the market in the Asia-Pacific is expected to witness rapid growth over the forecast period owing to rising incidences of PAD and increasing prevalence of diabetes. As per the estimates of the World Health Organization (WHO), approximately 77 million people above the age of 18 suffer from diabetes in India. Additionally, the rising preference for advanced treatment solutions and minimally invasive technologies coupled with growing emphasis on improving healthcare infrastructure are further expected to propel the market's expansion in the region.

Impact of the U.S. Tariff on Global Peripheral Vascular Devices Market

The key players of the market, such as Medtronic Inc. and Abbott Laboratories, are expected to face various challenges with the introduction of the tariffs. The increased costs may result in higher prices for consumers and potential reductions in research and development budgets, impacting innovation and availability of new devices.

Additionally, a large number of these devices rely on imported materials such as aluminum, steel, and specialized polymers, high tariffs on such materials are expected to disrupt supply chains and result in delays, boosting operational costs for medical device manufacturers. Healthcare providers and small hospitals are expected to experience financial strain due to the increased costs of medical devices, potentially leading to reduced accessibility to essential medical equipment for the patient population.

Key Players Landscape and Outlook

The key players of the market are focusing on launching new products and technologies in order to enhance physician convenience and expand their presence in the market. For instance, in June 2024, Koninklijke Philips N.V launched the Duo venous stent system for treating symptomatic venous outflow obstruction in patients suffering from chronic venous insufficiency. The innovative device was developed by Vesper Medical, Inc., a wholly owned subsidiary of Philips, however, the device is being marketed under the Philips brand name. As healthcare professionals seek evidence-based and cutting-edge diagnostic solutions for venous diseases, the introduction of such devices is setting standards for minimally invasive solutions that aid them in improving treatment outcomes.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product Type
      • 5.2.1.1. Peripheral Vascular Stents
        • 5.2.1.1.1. Balloon-expandable Stents
        • 5.2.1.1.2. Self-expanding Stents
        • 5.2.1.1.3. Drug-eluting Stents
        • 5.2.1.1.4. Bare-metal Stents
        • 5.2.1.1.5. Others
      • 5.2.1.2. Angioplasty Balloons
        • 5.2.1.2.1. Plain Old Balloon Angioplasty (POBA)
        • 5.2.1.2.2. Drug-coated Balloons (DCB)
        • 5.2.1.2.3. Scoring and Cutting Balloons
      • 5.2.1.3. Plaque Modification Devices
        • 5.2.1.3.1. Atherectomy Devices
        • 5.2.1.3.2. Thrombectomy Devices
      • 5.2.1.4. Inferior Vena Cava (IVC) Filters
        • 5.2.1.4.1. Permanent Filters
        • 5.2.1.4.2. Retrievable Filters
      • 5.2.1.5. Hemodynamic Flow Alteration Devices
        • 5.2.1.5.1. Chronic Total Occlusion Devices
        • 5.2.1.5.2. Embolic Protection Devices
      • 5.2.1.6. Catheters
        • 5.2.1.6.1. Angiography Catheters
        • 5.2.1.6.2. Guiding Catheters
        • 5.2.1.6.3. OCT Catheters
      • 5.2.1.7. Others
        • 5.2.1.7.1. Guidewires
        • 5.2.1.7.2. Vascular Closure Devices
        • 5.2.1.7.3. Introducer Sheaths
        • 5.2.1.7.4. Others
    • 5.2.2. By Application
      • 5.2.2.1. Peripheral Arterial Disease (PAD)
      • 5.2.2.2. Aneurysms
      • 5.2.2.3. Venous Thromboembolism
      • 5.2.2.4. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals and Surgical Centers
      • 5.2.3.2. Ambulatory Surgical Centers (ASCs)
      • 5.2.3.3. Academic and Research Institutes
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East and Africa
    • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Product Type
    • 5.3.2. By Application
    • 5.3.3. By End-user
    • 5.3.4. By Region

6. North America Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Product Type
      • 6.2.1.1. Peripheral Vascular Stents
        • 6.2.1.1.1. Balloon-expandable Stents
        • 6.2.1.1.2. Self-expanding Stents
        • 6.2.1.1.3. Drug-eluting Stents
        • 6.2.1.1.4. Bare-metal Stents
        • 6.2.1.1.5. Others
      • 6.2.1.2. Angioplasty Balloons
        • 6.2.1.2.1. Plain Old Balloon Angioplasty (POBA)
        • 6.2.1.2.2. Drug-coated Balloons (DCB)
        • 6.2.1.2.3. Scoring and Cutting Balloons
      • 6.2.1.3. Plaque Modification Devices
        • 6.2.1.3.1. Atherectomy Devices
        • 6.2.1.3.2. Thrombectomy Devices
      • 6.2.1.4. Inferior Vena Cava (IVC) Filters
        • 6.2.1.4.1. Permanent Filters
        • 6.2.1.4.2. Retrievable Filters
      • 6.2.1.5. Hemodynamic Flow Alteration Devices
        • 6.2.1.5.1. Chronic Total Occlusion Devices
        • 6.2.1.5.2. Embolic Protection Devices
      • 6.2.1.6. Catheters
        • 6.2.1.6.1. Angiography Catheters
        • 6.2.1.6.2. Guiding Catheters
        • 6.2.1.6.3. OCT Catheters
      • 6.2.1.7. Others
        • 6.2.1.7.1. Guidewires
        • 6.2.1.7.2. Vascular Closure Devices
        • 6.2.1.7.3. Introducer Sheaths
        • 6.2.1.7.4. Others
    • 6.2.2. By Application
      • 6.2.2.1. Peripheral Arterial Disease (PAD)
      • 6.2.2.2. Aneurysms
      • 6.2.2.3. Venous Thromboembolism
      • 6.2.2.4. Others
    • 6.2.3. By End-user
      • 6.2.3.1. Hospitals and Surgical Centers
      • 6.2.3.2. Ambulatory Surgical Centers (ASCs)
      • 6.2.3.3. Academic and Research Institutes
      • 6.2.3.4. Others
    • 6.2.4. By Country Share
      • 6.2.4.1. United States
      • 6.2.4.2. Canada
      • 6.2.4.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Peripheral Vascular Devices Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Product Type
          • 6.3.1.2.1.1. Peripheral Vascular Stents
          • 6.3.1.2.1.1.1. Balloon-expandable Stents
          • 6.3.1.2.1.1.2. Self-expanding Stents
          • 6.3.1.2.1.1.3. Drug-eluting Stents
          • 6.3.1.2.1.1.4. Bare-metal Stents
          • 6.3.1.2.1.1.5. Others
          • 6.3.1.2.1.2. Angioplasty Balloons
          • 6.3.1.2.1.2.1. Plain Old Balloon Angioplasty (POBA)
          • 6.3.1.2.1.2.2. Drug-coated Balloons (DCB)
          • 6.3.1.2.1.2.3. Scoring and Cutting Balloons
          • 6.3.1.2.1.3. Plaque Modification Devices
          • 6.3.1.2.1.3.1. Atherectomy Devices
          • 6.3.1.2.1.3.2. Thrombectomy Devices
          • 6.3.1.2.1.4. Inferior Vena Cava (IVC) Filters
          • 6.3.1.2.1.4.1. Permanent Filters
          • 6.3.1.2.1.4.2. Retrievable Filters
          • 6.3.1.2.1.5. Hemodynamic Flow Alteration Devices
          • 6.3.1.2.1.5.1. Chronic Total Occlusion Devices
          • 6.3.1.2.1.5.2. Embolic Protection Devices
          • 6.3.1.2.1.6. Catheters
          • 6.3.1.2.1.6.1. Angiography Catheters
          • 6.3.1.2.1.6.2. Guiding Catheters
          • 6.3.1.2.1.6.3. OCT Catheters
          • 6.3.1.2.1.7. Others
          • 6.3.1.2.1.7.1. Guidewires
          • 6.3.1.2.1.7.2. Vascular Closure Devices
          • 6.3.1.2.1.7.3. Introducer Sheaths
          • 6.3.1.2.1.7.4. Others
        • 6.3.1.2.2. By Application
          • 6.3.1.2.2.1. Peripheral Arterial Disease (PAD)
          • 6.3.1.2.2.2. Aneurysms
          • 6.3.1.2.2.3. Venous Thromboembolism
          • 6.3.1.2.2.4. Others
        • 6.3.1.2.3. By End-user
          • 6.3.1.2.3.1. Hospitals and Surgical Centers
          • 6.3.1.2.3.2. Ambulatory Surgical Centers (ASCs)
          • 6.3.1.2.3.3. Academic and Research Institutes
          • 6.3.1.2.3.4. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Peripheral Vascular Devices Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Landscape

20. Product Launches and Innovations

21. Case Studies

22. Competitive Landscape

  • 22.1. Competition Matrix of Top 5 Market Leaders
  • 22.2. SWOT Analysis for Top 5 Players
  • 22.3. Key Players Landscape for Top 10 Market Players
    • 22.3.1. Boston Scientific Corporation
      • 22.3.1.1. Company Details
      • 22.3.1.2. Key Management Personnel
      • 22.3.1.3. Products and Services
      • 22.3.1.4. Financials (As Reported)
      • 22.3.1.5. Key Market Focus and Geographical Presence
      • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 22.3.2. Koninklijke Philips N.V
    • 22.3.3. Abbott Laboratories
    • 22.3.4. Edward Lifesciences Corporation
    • 22.3.5. Medtronic Inc.
    • 22.3.6. Teleflex Incorporated
    • 22.3.7. Becton, Dickinson, and Company
    • 22.3.8. Edward Lifesciences Corporation
    • 22.3.9. Terumo Corporation
    • 22.3.10. Stryker Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer